According to the Zhitong Finance App, Sinopharm Holdings (01099.HK) announced Sinopharm's consistent results for the six months ended June 30, 2026, with total operating revenue of RMB 36.266 billion, down 1.44% year on year; net profit attributable to shareholders of listed companies was RMB 606 million, down 8.97% year on year; and basic earnings per share were 0.99 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.